BiomX Inc.

06/27/2022 | Press release | Distributed by Public on 06/27/2022 04:31

BiomX Announces Dosing of the First Two Patients in Phase 1b/2a Study of BX004 for Treatment of Chronic Respiratory Infections in Patients with Cystic Fibrosis